N?O Bond as a Glycosidic‐Bond Surrogate: Synthetic Studies Toward Polyhydroxylated N‐Alkoxypiperidines

A series of novel polyhydroxylated N‐alkoxypiperidines has been synthesized by ring‐closing double reductive amination (DRA) of highly functionalized 1,5‐dialdehydes with various hydroxylamines. The required saccharide‐based dialdehydes were prepared efficiently from sodium cyclopentadienylide in seven steps. A two‐step protocol has been developed for the DRA; it led, after deprotection, to isofagomine, 3‐deoxyisofagomine, and numerous other N‐alkoxy analogues. The barrier to inversion in these polyhydroxylated N‐alkoxypiperidine derivatives was found by variable‐temperature NMR methods to be approximately 15 kcal mol^?1. With the exception of N‐hydroxyisofagomine itself, none of the compounds prepared showed significant inhibitory activity against sweet almond β‐glucosidase.     

Efficiency of wollastonite and ammonium polyphosphate combinations on flame retardancy of polystyrene

The thermal and fire properties of polystyrene (PS) flame retarded by a system composed of ammonium polyphosphate (APP) and wollastonite (W) were investigated by thermogravimetric analysis, pyrolysis‐combustion flow calorimeter, pyrolysis gas chromatography mass spectrometry, cone calorimetry and epiradiator. The combustion residues were observed by scanning electron microscopy/energy dispersive X‐ray spectroscopy and analyzed by X‐ray diffraction. The combination of both additives enables increasing the thermal stability of PS while increasing simultaneously the high temperature residue. The peak of HRR was also significantly reduced while time to ignition varied depending on the composition. It was shown that the degradation pathway of PS was affected by the presence of the additives implying a reduction of the effective heat of combustion. In the condensed phase, APP decomposition promotes char formation and favors the reactivity between phosphorus and silicate. A layer composed of char, W and a mixture of calcium and silicon phosphate is formed at the sample surface during combustion. This layer is cohesive enough to limit the release of combustible gases to the gas phase. Moreover, the thermally stable protective layer reaches high temperature enabling the re‐irradiation of a part of the incident heat flux. The flame retardancy of PS is thus enhanced. Copyright © 2012 John Wiley & Sons, Ltd.     

Development of On-line Liquid Chromatography-Biochemical Detection for Soluble Epoxide Hydrolase Inhibitors in Mixtures

In this study, an end-point-based fluorescence assay for soluble epoxide hydrolase (sEH) was transformed into an on-line continuous-flow format. The on-line biochemical detection system (BCD) was coupled on-line to liquid chromatography (LC) to allow mixture analysis. The on-line BCD was based on a flow system wherein sEH activity was detected by competition of analytes with the substrate hydrolysis. The reaction product was measured by fluorescence detection. In parallel to the BCD data, UV and MS data were obtained through post-column splitting of the LC effluent. The buffer system and reagent concentrations were optimized resulting in a stable on-line BCD with a good assay window and good sensitivity (S/N > 60). The potency of known sEH inhibitors (sEHis) obtained by LC–BCD correlates well with published values. The LC–BCD system was applied to test how oxidative microsomal metabolism affects the potency of three sEHis. After incubation with pig liver microsomes, several metabolites of sEHis were characterized by MS, while their individual potencies were measured by BCD. For all compounds tested, active metabolites were observed. The developed method allows for the first time the detection of sEHis in mixtures providing new opportunities in the development of drug candidates.     

MCH-R1 Antagonist GPS18169, a Pseudopeptide,Is a Peripheral Anti-Obesity Agent in Mice

Melanin-concentrating hormone (MCH) is a 19 amino acid long peptide found in the brain of animals, including fishes, batrachians, and mammals. MCH is implicated in appetite and/or energy homeostasis. Antagonists at its receptor (MCH-R1) could be major tools (or ultimately drugs) to understand the mechanism of MCH action and to fight the obesity syndrome that is a worldwide societal health problem. Ever since the deorphanisation of the MCH receptor, we cloned, expressed, and characterized the receptor MCH-R1 and started a vast medicinal chemistry program aiming at the discovery of such usable compounds. In the present final work, we describe GPS18169, a pseudopeptide antagonist at the MCH-R1 receptor with an affinity in the nanomolar range and a Ki for its antagonistic effect in the 20 picomolar range. Its metabolic stability is rather ameliorated compared to its initial parent compound, the antagonist S38151. We tested it in an in vivo experiment using high diet mice. GPS18169 was found to be active in limiting the accumulation of adipose tissues and, correlatively, we observed a normalization of the insulin level in the treated animals, while no change in food or water consumption was observed.